Patents by Inventor Jean-Pierre Zanetta

Jean-Pierre Zanetta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds having a guanidine structure and pharmaceutical composition containing same
    Patent number: 5719187
    Abstract: Guanidine derivatives are provided useful for promoting growth, repair and regeneration of a neuronal axon and for treating neuropathies and myopathies. The compounds have the formula: ##STR1## wherein R.sub.1 is an isopropyl radical, a benzyl radical which is optionally substituted by one or more (C.sub.1 -C.sub.6)alkoxy radicals or a radical: ##STR2## R.sub.2, R.sub.3 and R.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 17, 1998
    Assignee: Centre National De La Recherche Scientifique(CNRS)
    Inventors: Claude Thal, Catherine Quirosa-Guillou, Pierre Potier, Dolor Renko, Jean-Pierre Zanetta, Marie-Madeleine Portier, Monique Sensenbrenner, Janine Koenig, Herbert Koenig
  • Compounds having a guanidine structure
    Patent number: 5480884
    Abstract: Compounds are provided useful for promoting growth, repair and regeneration of a neuronal axon and for treating neuropathies and myopathies having formula I ##STR1## wherein R.sub.2, R.sub.3 and R.sub.4 together with the nitrogen atoms to which they are attached forms a heterocyclic ring.
    Type: Grant
    Filed: July 22, 1993
    Date of Patent: January 2, 1996
    Assignee: Centre National De La Recherche Scientifique
    Inventors: Claude Thal, Catherine Quirosa-Guillou, Pierre Potier, Dolor Renko, Jean-Pierre Zanetta, Marie-Madeleine Portier, Monique Sensenbrenner, Janine Koenig, Herbert Koenig
  • Agents for the diagnosis of demyelinating neuropathies, in particular multiple sclerosis
    Patent number: 5225352
    Abstract: The invention relates to the use for the diagnosis of demyelinating neuropathies, in particular multiple sclerosis or MS, of endogenous lectins having an affinity for glycans rich in mannose or their protein subunits, these lectins or their subunits being immunologically related to the cerebellar soluble lectins (CSL or their protein subunits, respectively).
    Type: Grant
    Filed: September 5, 1990
    Date of Patent: July 6, 1993
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Jean-Pierre Zanetta, Jean-Marie Warter, Sabine Kuchler, Guy Vincendon